An increase in the number of joints affected by psoriatic arthritis doesn't usually lead to changes in TNF blocker treatment, this retrospective study shows. But changes in discontinuation over time and by gender are puzzling.
A new online journal club, RheumJC, launches with two live chats on Twitter on January 29. It's the first journal club ever in rheumatology, an opportunity for rheumatologists worldwide to discuss important published research.
(ACR 2014) A drug with a novel mechanism, sifalimumab, shows promise against lupus. In a video interview, Munther Khamastha MD describes the latest research into what could become a second new option for lupus patients.
Positioning of the probe is "three-quarters of the battle" in diagnosing synovitis of the wrist or hand, says Dr. DeMarco in this video. But gel technique and pressure are crucial to gaining accurate clinical information from ultrasound imaging of this condition.
(ACR14) (VIDEO) In tests so far, the infliximab biosimilar BOW015, just approved in India, seems to look about the same to the human immune system as the original. Here, a VP of the company behind BOW015 talks about the realities of seeking approval in the US.
(ACR2014) (VIDEO) In patients with knee osteoarthritis, which contributes more to the risk of central sensitization of pain: inflammation or injury? Dr. Tuhina Neogi reveals the answer in this video interview.